tiprankstipranks
pc:calde

Caldera Therapeutics Inc

Caldera Therapeutics is a clinical-stage biotechnology company developing first-in-class bispecific antibody therapeutics for inflammatory bowel disease (IBD) and other immunologic and inflammatory diseases. The company’s lead program, CLD-423, targets the IL-23p19 and TL1A pathways and was in-licensed for global development and commercialization from Qyuns Therapeutics Co., Ltd.

Leadership & Board

Currently, no data available

Latest Estimated Valuation

Estimated Valuation
Estimated Valuation
Total Amount Raised$38M
Total Amount Raised$38M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$38M
Latest Funding Amount$38M
Latest Funding RoundSeries A
Latest Funding RoundSeries A
Post-Money Valuation
Post-Money Valuation

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Jan 14, 2026
Series A
$37.50M

Investors

Investor Name
Funding Round

Related News and Analysis